Contact your wholesaler or our customer service center to order ACETADOTE
Customer Service Center:
Phone: (877) 274-7200
Fax: (614) 652-9127
Administer ACETADOTE for accurate dosing
- Approved for pediatric dosing
- Patient's level of consciousness does not limit I.V. administration
How Supplied
ACETADOTE (acetylcysteine) injection is available as a 20% solution (200 mg/mL) in 30 mL single dose vials. ACETADOTE is sterile and can be used for I.V. administration. It is available as follows:
- 30 mL vials, carton of 4 (NDC 66220-107-30)
Do not use previously opened vials for I.V. administration.
Available by Prescription Only
HCPS code J0132 (Please refer to your coding department for complete billing information.)
Important Safety Information
ACETADOTE is contraindicated in patients with hypersensitivity or previous anaphylactoid reactions to acetylcysteine or any components of the preparation. Serious anaphylactoid reactions, including death in a patient with asthma, have been reported in patients administered acetylcysteine intravenously.
ACETADOTE should be used with caution in patients with asthma, or where there is a history of bronchospasm. The total volume administered should be adjusted for patients less than 40 kg and for those requiring fluid restriction. To avoid fluid overload, the volume of diluent should be reduced as needed. If volume is not adjusted, fluid overload can occur, potentially resulting in hyponatremia, seizure, and death.
Indications and Usage
Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.
References
1. Data on file, Cumberland Pharmaceuticals Inc.